Indonesia pledges $30 million to support Gavi’s global immunisation efforts for 2026–2030 

This commitment marks Indonesia’s debut as a Gavi donor and the first-ever pledge from a middle-income country toward Gavi’s replenishment efforts for its next strategic phase.

Gavi emphasized that Indonesia’s pledge is a testament to the effectiveness of the Alliance’s focus on partnering with countries to build self-sustaining immunisation systems.

The contribution also underscores Indonesia’s global health leadership and championing of the critical role vaccines play in building healthier, safer, and more prosperous communities worldwide.

Indonesia’s immunisation story is one of transformation and progress. Over the course of 22 years of partnership with Gavi, the country has doubled the number of vaccines offered through its routine immunisation programme, reduced child mortality by four-fold, and has transitioned through all stages of Gavi support.

Now independently sustaining its immunisation efforts, Indonesia continues to receive some targeted support to ensure equitable access to high-impact vaccines, through Gavi’s flexible approach to partnering with middle-income countries.

The country’s evolution to becoming a Gavi donor showcases the impact sustained investment in health can have on a country’s future.

Professor José Manuel Barroso, Chair of the Gavi Board said we welcome with deep gratitude this pledge, as well as Indonesia’s continued commitment to championing the vital importance of immunisation in building a healthier, safer, and more equitable world.

“Indonesia’s extraordinary journey with Gavi underscores how sustainable investments in vaccines can transform lives, health systems, and countries,” he stated.

Dr Sania Nishtar, CEO of Gavi emphasized that Indonesia’s contribution is a testament to the long-term impact of Gavi’s model and the strength of its partnerships.

“As a country that has achieved remarkable success with Gavi’s support, Indonesia is now paying it forward, ensuring other nations can benefit from the same life-saving interventions,” she said.

Gavi has announced that it has immunised over 1.1 billion children since its establishment, saving more than 18 million lives and halving childhood mortality in the lower-income countries where it operates.

The event, set to take place in Brussels in early 2025, will bring together leaders from governments, partner organisations, vaccine manufacturers, civil society, and the private sector.

Gavi 6.0 is the Vaccine Alliance’s new strategic phase for the period 2026-2030, with ambitious goals and a clear strategy aimed at continuing and expanding its global impact.

One of the primary objectives is to reduce child mortality by increasing immunisation rates across the world, especially in the most vulnerable communities in lower-income and fragile countries.